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Abstract
Mycobacterium avium subsp. paratuberculosis (MAP) is an intracellular pathogen and is the causative agent of
Johne’s disease of domestic and wild ruminants. Johne’s disease is characterized by chronic granulomatous enteritis
leading to substantial economic losses to the livestock sector across the world. MAP persistently survives in
phagocytic cells, most commonly in macrophages by disrupting its early antibacterial activity. MAP triggers several
signaling pathways after attachment to pathogen recognition receptors (PRRs) of phagocytic cells. MAP adopts a
survival strategy to escape the host defence mechanisms via the activation of mitogen-activated protein kinase
(MAPK) pathway. The signaling mechanism initiated through toll like receptor 2 (TLR2) activates MAPK-p38 results in
up-regulation of interleukin-10 (IL-10), and subsequent repression of inflammatory cytokines. The anti-inflammatory
response of IL-10 is mediated through membrane-bound IL-10 receptors, leading to trans-phosphorylation and
activation of Janus Kinase (JAK) family receptor-associated tyrosine kinases (TyKs), that promotes the activation of
latent transcription factors, signal transducer and activators of transcription 3 (STAT3). IL-10 is an important
inhibitory cytokine playing its role in blocking phagosome maturation and apoptosis. In the current review, we
describe the importance of IL-10 in early phases of the MAP infection and regulatory mechanisms of the IL-10
dependent pathways in paratuberculosis. We also highlight the strategies to target IL-10, MAPK and STAT3 in other
infections caused by intracellular pathogens.
Keywords: Mycobacterium avium subsp. paratuberculosis (MAP), Mitogen-activated protein kinase (MAPK), Toll like
receptor 2 (TLR2), Interleukin-10 (IL-10), Janus Kinase (JAK), Signal transducer and activators of transcription-3
(STAT3)
Background
Mycobacterium avium subsp. paratuberculosis (MAP) is
the causative agent of paratuberculosis or Johne’s disease
(JD), chronic progressive granulomatous enteritis in ru-
minants. This disease was first described by Dr. Heinrich
Albert Johne and Dr. Herman Markus in 1895, during
examination of a cow’s intestine with a history of re-
duced milk production and progressive emaciation [1].
The pathogenesis of paratuberculosis is divided into
three distinct phases: Silent infection phase, with the ap-
pearance of no clinical signs, but animals intermittently
shed MAP in the faeces, Subclinical phase: there is an
altered immune response with no weight loss or
diarrhoea [2], while clinical disease phase: characterized
by profuse diarrhoea, marked weight loss, that can be di-
agnosed by routine MAP detecting procedures [3]. In
the clinical phase majority of the animals die due to se-
vere dehydration and emaciation [1, 4]. Apart from com-
mon domesticated animals such as cattle, sheep and
goats MAP also infect a wide range of other wild rumi-
nants such as deer [5, 6]. The most common route of in-
fection is fecal-oral for all age of animals, while calves
can also get the infection via contaminated milk. MAP is
also detected in the saliva of cows, indicating that saliva
might be a potential mode of transmission [7–9]. Serious
economic losses from paratuberculosis occurs due to
early culling of the animals with decreased milk produc-
tion on one hand, but on the other hand loss of capital
investments in treating secondary infections, such as
mastitis and reduced fertility [10]. Paratuberculosis is
also considered a potential zoonotic threat. In 1913,
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Dalziel reported the link between MAP and human
Morbus Crohn disease (CD). Several studies have demon-
strated the presence of MAP in CD cases, but the causa-
tive role of MAP in CD is not established yet [11, 12].
Similarly McNees and colleagues reported that MAP can
be cultured from mononuclear cells of Crohn’s disease pa-
tient’s but it does not establish the etiology [13].
Immunological responses observed in paratuberculosis
begin with a robust T-helper1 (Th1) type response pre-
dominantly enhanced interferon-gamma (IFN-γ) produc-
tion [14, 15]. The hallmark of paratuberculosis is shift in
immune response from a cell mediated Th1-type re-
sponse to a humoral T helper2 (Th2) type response with
the progression of disease from a subclinical to clinical
phase [16]. Similarly, in ovine model of paratuberculosis,
it is observed that the cellular immune response attenu-
ates in natural and experimental MAP infected animals
in more advanced phase of disease [17]. MAP rapidly
(within 6–24 h) shutdown the pro-inflammatory T cell
immune response by promoting immunosuppressive cy-
tokines (IL-10, TGF-β) in in-vitro models . Impairment
of CD40 signaling, which is an important macrophage
receptor for CD40L on Th1 cells to maintain a Th1 im-
mune response [18]. Mononuclear phagocytic cells
(Macrophages), serves as intracellular niche for the
MAP survival and multiplication. Macrophages have
several pathogen recognition receptors (PRRs), involved
in the uptake of mycobacteria [19, 20]. Toll like recep-
tors are family of cell membrane receptors that initiate
cell signaling associated with mycobacterium infection
[21]. Several studies indicated that pathogenic mycobac-
teria signal through TLR2 to suppress macrophage anti-
microbial responses and antigen presentations [22, 23].
MAP initiates signaling via binding with TLR2 of bovine
mononuclear phagocytic cells that result in the activa-
tion of MAPK-p38 with a high level of IL-10 production
and low level of IL-12 [24–27]. Pathogenic mycobcteria
contains mannosylated lipoarabinomannan (Man-LAM)
while arabinosylated lipoarabinomannan (Ara-LAM) is
usually found in the cell wall of non-pathogenic myco-
bacteria. Man-LAM is one of the important pathogen
associated molecular pattern (PAMP) of MAP that ligate
with TLR2 to enhance IL-10 production as well as transi-
ent expression of tumor necrosis factor alpha (TNF-α)
[26]. Furthermore, it is reported that antigen recognition
via TLR2/4 and CD14 in in-vitro and in-vivo lead to over-
secretion of IL-10 by disrupting inflammatory responses
and generation of adoptive immunity, thereby providing a
niche for the persistent survival of pathogen [28].
IL-10 is a potent anti-inflammatory cytokine, crucial
for down-regulating pro-inflammatory genes, induced by
TLR signaling [29]. IL-10 is not only an essential immu-
noregulator in host immunity, but it also accounts for
the intracellular survival of mycobacterium due to its
inhibitory activity against anti-mycobacterial functions
of macrophages [30]. The absence of IL-10 leads to bet-
ter clearance of some pathogens with no enhanced
immuno-pathology [31, 32]. The level of IL-10 produc-
tion depends on the type and strength of the stimulus,
while the molecular mechanisms for the regulation of
IL-10 differ according to cell type, although some com-
mon mechanisms also exist [33]. The main signaling
pathways for the production and regulation of IL-10 in
phagocytic cells are mitogen-activated protein kinases
(MAPKs) pathways, nuclear factor kappa-B (NF-kB) and
signal transducer and activators of transcription-3
(STAT3). IL-10 is known to suppress macrophage activa-
tion and down-regulate anti-inflammatory and anti-
microbial responses such as the production of nitric
oxide (NO2), TNF-α, and IL-12 [34, 35]. IL-10 promotes
the viability of host cells by inhibiting autophagy, via acti-
vating B-cell lypmphoma2 (Bcl2) [36]. Feng and colleagues
reported that transgenic mice expressing human IL-10
under the control of major histocompatibility complex
class II promoter (hu10Tg) were more susceptible to MAP
infection than the wild-type mice. In addition, hu10Tg
mice strongly inhibited anti-mycobacterial response of the
macrophages such as apoptosis, production of TNF, nitric
oxide, and IL-12p40 [37].
Successful phagolysosomal maturation is an important
innate immune response for the clearance of intracellular
pathogens. MAPK-p38 plays an important role in the sig-
naling cascades during mycobacterial infection [38–40]
and is associated with arresting phagosome–lysosome fu-
sion and maturation [41]. MAP interference with phago-
some maturation in the infected macrophages depends on
the MAPK-p38 signaling pathway activated by Man-LAM
and also plays a role in the survival of Mycobacterium
avium subsp avium (MAA) [26]. Interestingly, it was ob-
served that Man-LAM but not Ara-LAM induce IL-10 se-
cretion in LPS stimulating DCs [42]. IL-10 also mediates
its anti-inflammatory effects on macrophages by signaling
through STAT3 [43, 44]. STAT3 plays an important role
as a signaling mediator of IL-6 and IL-10 family members
and other cytokines [45]. The blocking of IL-10 in Myco-
bacterium tuberculosis (Mtb) infected macrophages, al-
lows phagosome maturation, but the addition of IL-10 to
cells infected with killed Mtb successfully inhibits its mat-
uration, resulting in enhanced survival of Mtb via inhibit-
ing phagosome maturation by IL-10 [46]. Moreover, it is
reported that IL-10 secreting transgenic mice were unable
to clear the infection and developed bacterial burden after
being challenged with BCG (Mycobacterium bovis), sug-
gesting that IL-10 help in mycobacterial infection [47]. On
the other hand the blocking of IL-10 in Mtb susceptible
CBA/J mice minimized the pulmonary bacterial load and
improved the animal survival during chronic infection
[48]. In MAP infection it has been investigated that the
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over expression of IL-10 dependent MAPK-p38 [24] is as-
sociated with the survival of macrophages by inhibiting
the apoptosis phenomenon [35]. IL-10 negatively regulate
apoptosis via the activation of STAT3 to promote the
transcription of anti-apoptotic and cell cycle progression
genes such as BCLXL, CyclinD1, CyclinD2, CyclinD3, and
CyclinA, Pim1, c-Myc and p19 (INK4D) [49].
It is clear from previous studies that IL-10 regulation
can be a potential hotspot for devising therapeutic mea-
sures in intracellular pathogens including MAP. IL-10
regulation can be exploited through recently developed
microRNAs (miRNAs) controlling strategies. Several
microRNAs regulate the expression of IL-10 by targeting
its transcription at 3UTR or by targeting pathways that
regulate IL-10 production. Apart from miRNAs, several
compounds such as ammonium trichloro (dioxoethy-
lene-O, O’) tellurate (AS101), SD169 and an antihel-
minth niclosamide can be used to inhibit IL-10
mediated anti-inflammatory activity that has already
shown promising results in various infections.
The role of IL-10 in paratuberculosis
The role of IL-10 is well established in paratuberculosis,
as IL-10 plays an important role in the cross talk be-
tween innate and adoptive immune responses of the
host. IL-10 mediated suppression of IFN-γ secretion in
peripheral blood of cattle and goats exposed to MAP in-
fection is also documented [50, 51]. MAP stimulates IL-
10 secretion from ovine and bovine monocytes derived
antigen presenting cells [52–54]. Coussens and col-
leagues investigated the expression of cytokine genes in
Peripheral blood mononuclear cells (PBMC) of subclin-
ical paratuberculosed and disease-free animals, an in-
crease of IFN-γ gene expression was observed in
subclinical animals, while in-vitro stimulation did not
show any increase in the expression of IFN-γ. In con-
trast, IL-10 gene expression was low in unstimulated
cells from both groups, but MAP stimulated cells
showed an enhanced expression of IL-10 in subclinically
infected animals in comparison of number of cytokines,
including IFN-γ, TGF-β, TNF-α, IL-1α, IL-4, IL-6, IL-8,
and IL-12p35 [55]. Janagama and colleagues investigated
that bovine monocyte derived macrophages (BMDM)
stimulated with bovine MAP isolate (MAP1018) up-
regulated IL-10 at the transcript level and down-
regulated TNF-α at both protein and transcript levels in
BMDM cells compared with human and sheep MAP
(MAP S7565) isolates [56]. Man-LAM of MAP has been
identified as one of the ligands that modulates macro-
phage function and induce a rapid and prolonged
expression of IL-10 as well as transient expression of
TNF-α [26]. Khalifeh and Stabel also found that IL-10
secretion was elevated upon incubation of live MAP
with PBMC from naturally infected cattle, when
compared to healthy animals [38]. In ovine paratubercu-
losis, animals with paucibacillary (type of lesions largely
composed of lymphocytes with some macrophages and
giant cells and few acid-fast bacteria) disease are more
likely to have elevated levels of IFN-γ in illeal tissue
while elevated levels of IL-10 are more likely in multiba-
cillary (type of lesions contain few lymphocytes and nu-
merous clusters of macrophages having acid-fast
bacteria) animals [57]. Narnaware and colleagues also re-
ported that MAP baison strain upregulate both TGF-β
and IL-10 genes in paucibacillary and multibacillary
cases in bullocks while a higher magnitude of anti-
inflammatory cytokines were observed in animals of
multibacillary lesions [58].
IL-10 is an important immunoregulator on one hand,
but on the other hand it inhibits anti-mycobacterial ac-
tivity of macrophages and promotes the intracellular sur-
vival of mycobacteria [30]. Previously it was reported
that Map41, one of important recombinant protein of
MAP that elicited IFN-γ production in PBMC from cat-
tle infected with MAP [59]. In the study of Reiko and
colleagues it was observed that there is an increased pro-
duction of IL-10 in response to Map41 from experimen-
tally infected calves as early as 2–4 weeks than that of
IFN-γ. This characteristic expression of IL-10 in MAP-
infected cattle seems to be playing important role in the
pathogenesis of paratuberculosis, and could be an im-
portant diagnostic indicator [30]. Further studies re-
vealed that the blood cells from calves immunized with
MAP produced higher amounts of IL-10 against Map41
stimulation than those calves immunized with various
mycobacterium species, in addition, experimentally in-
fected guinea pigs with 14 various mycobacterium spe-
cies showed high specificity of IL-10 production to MAP
after stimulation of splenocytes by Map41 recombinant
protein [30]. John et al., [27] also showed that specific
MAP recombinant proteins induced an elevated expres-
sion of IL-10 by macrophages whereas other proteins
are involved in survival of mycobacteria within the mac-
rophages as well as activating the MAPKp38 pathway
[27]. M. avium 101 infected C57BLJ6 mice produced
peak IL-10 after 2 weeks of infection and remained high
throughout the period of infection. Further investiga-
tions on the role of IL-10 in the survival of M. avium
101, mice were infected and simultaneously treated with
anti-IL-10 antibodies resulted in 2 to 3 log unit less bac-
terial load in the spleen and liver than the control mice
[60]. Another study reported that BALB/c mice were
more susceptible to M. avium infection while the reduc-
tion of IL-10 activity in these animals through anti-IL-
10R mAb, or by using IL-10 knockout mice reduced the
susceptibility to M. avium infection. Moreover, the in-
hibition of IL-10 also increased the efficacy of anti-
mycobacterial therapy in infected BALB/c mice [61].
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Similarly, when the level of IL-10 was increased by using
recombinant IL-10 or IL-10 transgenic mice, animals
were more prone to disease [62, 63]. These findings re-
garding the over production of IL-10 in MAP infected
animals as well as MAP or Map recombinant proteins
stimulating macrophages suggest the importance of IL-
10 in the progression of paratuberculosis.
The role of IL-10 mediated inhibition of proinflammatory
cytokines in paratuberculosis
During mycobacterial infections, cytokine networks trig-
gered by macrophages generally determine the outcome
of an infection [64]. IL-10 also inhibits the antimicrobial
activity of macrophages by down regulating the expres-
sion of IL-12 and TNF-α [34, 65]. Previous studies
shown that IL-10 act as a possible mediator of immuno-
suppressants associated with MAP infection [35, 52].
Investigations on bovine monocytes treated with anti-IL-
10 antibodies before challenge with MAP showed an
over expression of IL-12, TNF-α and also promoted the
bactericidal activity of these cells [65]. Earlier studies re-
ported that IFN-γ and TNF-α plays a key role in the
control of intracellular Mtb [64, 66]. IL-12 is one of the
important pro-inflammatory cytokine produced primar-
ily by antigen-presenting cells (APCs), including mono-
cytes/macrophages and dendritic cells [67]. IL-12 is
composed of p35 (encoded by Il12a) and p40 (encoded
by Il12b) chains, and it principally activates natural killer
(NK) cells and induce the differentiation of naive CD4+
T lymphocytes to become IFN-γ producing Th1 effecter
cells [67]. IFN-γ, acts on APCs to augment IL-12 secre-
tion in a positive feedback loop [68, 69]. On the other
hand, the most important and well studied negative
regulator of TLR-induced IL-12 production is IL-10 [70].
IL-10 suppresses the production of IL-12 at transcrip-
tional level by down regulating both IL12a and Il12b
genes [71]. IL-10 overexpressed transgenic mice chal-
lenged with Mtb via respiratory route shown a highly
significant increase in bacterial number in the lungs,
while decreased mRNA production of TNF-α and IL-
12p40, and a marked decrease in the secretion of Ag-
specific IFN-γ was observed [72].
IL-10 is induced in many situations together with pro-
inflammatory cytokines, although the pathways that in-
duce IL-10 expression more likely negatively regulate
the expression of these pro-inflammatory cytokines [33].
Dendritic cells (DC) and macrophages produce TNF-α
as a primary response of infection and tissue damage,
plays an important role in activation and recruitment of
leukocytes [73], and has been demonstrated to be in-
volved in the host defence against Mtb [74]. IL-10 re-
quires Stat3, Jak1, and two distinct regions of the IL-10
receptor intracellular domain to inhibit TNF-α produc-
tion in lipopolysaccharide stimulated macrophages.
Macrophages deficient in Stat3 or Jak1 are unable to in-
hibit lipopolysaccharide induced TNF-α production fol-
lowing treatment with murine IL-10 [75]. IFN-γ is a key
molecule that helps in the activation of macrophages
with the production of reactive oxygen and nitrogen spe-
cies, activation of T cells and maturation of DCs [76].
IFN-γ is the early marker of cell-mediated immune
response and essential for effective clearance of the
mycobacteria, but with the progression of disease, an im-
munosuppressive cytokine IL-10 becomes predominant
[50, 51]. An enhanced host generated IFN-γ and IL-17A
were observed in CBA/J mice during BCG vaccination re-
sulted in additional protection against Mtb by inhibition
of IL-10 activity through anti-IL-10R mAb treatment [77].
In the clinical stages of paratuberculosis, it was observed
that IL-10 suppressed the production of IFN-γ [38].
Neutralization of IL-10 in vitro resulted in increased IL-
12, TNF-α, and IFN-γ mRNA expression by bovine mono-
cytes exposed to MAP or purified protein derivative
(Johnin) [50]. Mice deficient in IL-10 eliminated M.bovis
BCG faster than wild-type mice, while macrophages in the
granulomas expressed high level of MHC class II mol-
ecule, TNF-α, acid phosphatase and inducible nitric oxide
sythase (iNOS) [78]. The serine/threonine protein kinase
C (PKC) theta plays an important role in host defence
against Salmonella typhimurium, as resulted in high num-
ber of bacteria in spleen and liver of PKC theta−/− mice.
Furthermore PKC theta-deficient macrophage expressed
significantly higher levels of IL-10 in in-vivo and in-vitro
when challenged with S.typhimurium or LPS/IFN-γ while
neutralization of IL-10 improved the control of S.typhi-
murium infection in PKC theta deficient macrophages
[79]. It has been shown that the exogenous treatment of
IL-10 inhibit macrophage function like the release of NO
and TNF-α, IL-6, and GM-CSF secretion, induced by LPS
[80]. Taken together IL-10 enhances the growth and per-
sistent survival of MAP in phagocytic cells by inhibiting
the secretion of pro-inflammatory cytokines.
The role of IL-10 in the shift of immune responses
from Th1 to Th2 dominated immune responses in
paratuberculosis infection
The progression of paratuberculosis from subclinical to
clinical form is mainly dependent on a gradual shift in
immune response from a cell-mediated Th1 type re-
sponse to a humoral Th2 response [16]. The naive
helper T cells mainly differentiate into either Th1 cells
or Th2 cells effecter cells after activation. The Th1 cells
secrete IFN-γ and TNF-α and activate macrophages to
kill microbes located within the phagosomes. On the
other hand Th2 cells secrete interleukins 4, 5, 10, and 13
(IL-4, IL-5, IL-10, and IL-13) and will mainly defend the
animal against extracellular pathogens (Fig. 1). Initially,
Th2 cells were the main populations of T cells that
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produce IL-10 in a sustained manner [81, 82]. One the-
ory suggests that the differentiation of naive T cell into
subpopulation of Th1/Th2 cells based on the host im-
mune response mediated by polarization of APCs (Fig. 1)
after initial contact with an antigen [83]. The early stage
of paratuberculosis is controlled by a cell-mediated Th1
response activated by infected macrophages that express
IFN-γ, IL-12 and TNF-α [84]. IFN-γ and TNF-α are
important cytokines of the Th1 response, enhancing bac-
tericidal activity of macrophages with the production of
reactive oxygen and nitrogen species, activation of T
cells and maturation of DCs [76, 85]. Another important
role for IFN-γ is the induction of IL-12 which further di-
rects CD4 cells to the Th1 subset. Studies have demon-
strated that CD4 cells are also the primary source of
IFN-γ in MAP infection [86]. In response to mycobac-
terial infection, different cytokines like IL-12, IL-17 and
IL-23 contribute in the development of Th1 cells [87].
During MAP infection, Th1-type response usually occurs
early in the infection cycle with an increase production
of IFN-γ [88]. De Silva and colleagues reported that IL-
10 mediated Th2 response becomes dominant when the
disease is in progress, with a decline in Th1 response.
Similarly Begg and colleagues reported that during clin-
ical stage of the disease Th2 type immune responses are
more dominant than Th1 type. Further studies suggest
that there is a classical switch between Th-1/Th-2 im-
mune response in ruminants infected with MAP [17].
During Mtb infection various type of T helper cells
(such as Th1, Th2, Th17, and regulatory T cells) are
present but Th1 type of cells are more commonly in-
volved in impaired growth and dispersion of Mtb [89].
In sheep MAP infection, paucibacillary lesions have been
correlated with a stronger cell-mediated Th1 response
Fig. 1 A classical switch between Th-1/Th-2 immune response in paratuberculosis: Navi Th cell differentiate into subpopulation of effectors Th
cells when bind to antigen presented by antigen presenting cell (APC). In MAP infection the early differentiated effectors T helper1 (Th1) cell
promote protective cell mediate immune response. Th1 cell secrets cytokines such as interferon-gamma (INF-γ) and Interleukin-12(IL-12) and
promote the activation of macrophages. In the later stages of infection T helper 2 (Th2) and regulatory T cell are dominant. Th2 and T-reg cell
secret anti-inflammatory cytokines such as IL-4, IL-5, IL-10, IL-13 and TGF-β. These anti-inflammatory cytokines block the activation of macrophages
and also down-regulate the cytokines secreted by Th1 cell and prevent cell mediated immune response while promote humoral response
mediated by Th2 cell
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than those with multibacillary lesions with a high level
of IL-10 expression [88, 90]. A similar trend of higher
levels of Th2 type cytokines IL-4, IL-10, IL-2 were ob-
served in cattle with multibacillary lesions [91]. Recent
studies also demonstrated that high expressions of IL-10
and TGF-β in the advanced stage of MAP infection with
a diffuse granulomatous lesions, suggest the predomin-
ance of Th2 response, which shows a switch of Th1 to
Th2 response. In addition, an increased expression of
IL-10 and TGF-β could have limited Th1 cytokines and
cellular infiltration resulting in less tissue pathology but
persistence of MAP infection in bullocks [58].
The role of IL-10 predicted with the cytokine signaling
model is similar to the cell model where IL-10 can en-
hance the Th2 response and suppress the Th1 response
which promotes the progression of disease [92]. IL-10 is
implicated at many levels of tuberculosis disease, such as
directing Th2-type cell expansion in the lung [92, 93].
Several studies shown that some molecular mechanisms
exist that cause a switch from IFN-γ production to IL-10
by Th1 cells. It is predicted that IL-4 favor the expres-
sion of IL-10, also reported by Gesham et al. [92] that
IL-4 inhibit Th1 (IFN-γ) response. In Mtb, IL-10 also
block the migration of T cell to the site of infection most
commonly impairing the recruitment of Th1 cells to the
lungs of infected mice [94]. Hence the control of Mtb is
negatively regulated by IL-10 and inhibit the progression
of early innate to late adoptive Th1 response [94]. Simi-
larly, another intracellular pathogen Ehrlichia muris in-
duced early IL-10 production which impaired bacterial
clearance in wild-type mice and deteriorate IFN-γ pro-
duction while in IL-10 deficient mice IFN-γ production
by CD4 T cell was restored and induced a protective im-
mune response [95]. The lack of IL-10 production by T
cells resulted in an increased ability of mice to control
intracellular Brucella abortus infection and elevated the
production of pro-inflammatory cytokines. Moreover it
is suggested that early IL-10 production by CD25 + CD4+
T cells modulates macrophage activation that is beneficial
for bacterial survival and persistent infection [96]. In the
clinical form of paratuberculosis, it is observed that Th2
type response dominate with an increased level of cyto-
kines such as IL-4, IL-5 and IL-10 [84, 97]. The dynamics
of IL-10, TGF-β and IFN-γ gene expression in the ileum,
ileocecal junction, ileocecal lymph node, and mesenteric
lymph nodes of healthy cows as well as those in subclin-
ical and clinical stages of infection. IL-10 and TGF-β
mRNA levels were significantly higher in all tissues of
cows with clinical disease. In contrast, IFN-γ gene expres-
sion was significantly higher only in animals with subclin-
ical infection [52]. These reports suggest that IL-10
production during paratuberculosis gradually shift pro-
tective Th1 cell mediated immune response to humoral
response mediated by Th2 cells.
The role of IL-10 mediated inhibition of phagosome
maturation in paratuberculosis
Phagocytosis is an essential process by which macro-
phages engulf invading pathogens, apoptotic cells and
other foreign particles. Phagocytosis triggers the activa-
tion of multiple transmembrane signaling pathways that
lead to the formation of a sealed intracellular compart-
ment called phagosome [98]. Pathogenic species of
mycobacteria have evolved mechanisms that enhance
their survival ability within macrophages by inhibiting
acidification and maturation of phagosomal compart-
ment which is necessary for the progression of a phago-
some into a functional phagolysosome [99, 100]. MAP
adopts multiple strategies for their intracellular survival;
one of them involves the inhibition of phagosomal acid-
ification and maturation. MAP blocks the phagosome
maturation into phagolysosome by interfering the
localization of lysosomal markers and prevents the pH
to go below 6.3 in J774 macrophages [101]. Previous
studies reported that MAP enhances the phosphoryl-
ation of MAPK-p38 in bovine monocytes, resulted in the
inhibition of phagosomal acidification and killing of
MAP to over-express IL-10 [24]. While the inhibition of
p38 phosphorylation by the application of pharmaco-
logically active substances enhance the bactericidal activ-
ity of bovine monocytes against MAP organism and
increase the acidification of phagosome [21, 24, 35]. IL-
10 negatively regulates the maturation of phagosome in
Mtb [46]. Man-LAM from MAP interacts with PRRs of
macrophages promote IL-10 production and further
inhibit phagosomal acidification [26]. Other studies
showed that monocytes treated with p38 inhibitor before
challenging with MAP and Mtb promote phagosomal
maturation and also inhibit IL-10 production [41, 46]. In
addition, macrophages treated with cytokines lead to
an increase in the acidification and maturation of
phagosomal compartments containing MAP [102].
Furthermore, phagosome maturation was enhanced by
blocking STAT3 activity in Mtb-infected macrophages
[46]. The acidification of phagosomal compartment in
macrophages infected by pathogenic mycobacteria is
inhibited through the elimination of phagosomal pro-
ton pump, the Vacuolar Hþ ATPase (V-ATPase), from
their phagosomal membranes [103]. Phagosomal body
having MAP or Mtb are deficient in V-ATPase [99].
It is clear from the above findings that p38 phoshory-
lation promote IL-10 production and further increase
MAP resistance to defence mechanisms of the host
by blocking the acidification and maturation of
phagosomal compartments.
Role of IL-10 mediated apoptosis in paratuberculosis
The process of programme cell death (apoptosis) is also
an essential mechanism of the host for the control of
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intracellular infections [103]. However, some pathogens
may prevent host cell apoptosis, circumventing effero-
cytosis, and ensuring limited immune system detection
[104]. MAP keeps the host cell alive by preventing
apoptotic suicide of macrophages. Macrophages in-
fected with mycobacteria tend to activate apoptotic
pathways, resulting in cell death [105]. However, patho-
genic strains of mycobacteria induce less apoptosis as
compared to low pathogenic strains. For example, bo-
vine monocyte-derived macrophages (BMDM) have a
greater percentage of apoptotic cells when incubated
with the less pathogenic organism MAA in comparison
to bovine pathogen MAP [106]. Pathogenic mycobac-
teria also limit apoptosis by inhibiting TNF-α expres-
sion and releasing soluble TNF-receptor-2 (TNFR2)
that neutralize TNF-α activity [105]. This is accom-
plished primarily through over expression of IL-10 [35,
107]. IL-10 not only suppresses TNF-α synthesis but
also enhance soluble TNFR2 [105]. High concentration
of IL-10 also impairs apoptosis induced by Mtb in
alveolar macrophages [108]. IL-10 significantly up-
regulates the expression of suppressor of cytokine
signaling-3 (SOCS3), and modulates oxidized low-
density lipoprotein (oxLDL) to inhibit apoptosis in
endothelial cells [109]. It has been reported that IL-10
inhibits the production of inflammatory cytokines by
macrophages and protect cell from apoptosis [110]. In
addition, IL-10 induces its anti-apoptotic properties via
overexpression of SOCS3 that inhibit inflammatory
cytokine involved in the progression of apoptosis. This
phenomenon was also reported in a recent study show-
ing that SOCS3 and SOCS1 suppressed cytokine-
induced apoptosis [111]. IL-10 also prevents apoptotic
cell death of infected macrophages by inhibiting mul-
tiple components that positively regulate apoptosis phe-
nomena and promote the survival of MAP.
IL-10 regulating signaling pathways
Phagocytic cells have various pathogen recognition recep-
tors (PRRs) for initiating signaling cascades. Among differ-
ent PRRs TLRs are important pattern recognition
receptors of phagocytic cells, signaling pathways followed
by TLR2 and TLR4 are potent inducers of IL-10 [112]. It
has been suggested that TLR2 agonists are specialized in
inducing IL-10 expression by APCs [112, 113]. Several
studies indicate that pathogenic mycobacteria signal
through TLR2 is crucial for the induction of IL-10, sup-
press macrophage antimicrobial responses and antigen
presentation [114]. TLR2/4 is major signaling receptors of
phagocytic cells activate MAPK pathway and may activate
the NF-kB pathway after ligation with Man-LAM and
19 kDa of MAP [25]. The common signaling pathways
that induce the regulation of IL-10 in phagocytic cells are
MAPK, NF-kB, and STAT [25, 43].
MAPK pathway
Mitogen-activated protein kinase (MAPK) is a signal
transduction pathway belongs to a large family of serine/
threonine kinases, which constitute major inflammatory
signaling pathways from the cell surface to the nucleus
[115]. There are three well-characterized subfamilies of
MAPKs: the extracellular signal-regulated kinases (ERK),
the c-Jun NH2-terminal kinases (JNK), and the p38 fam-
ily of kinases (p38 MAPKs) [116, 117]. Both ERK and
p38 are crucial for the Mtb-induced production of TNF-
α, while p38 is more essential for the secretion of IL-10
in macrophage [40]. MAP induced IL-10 expression by
bovine monocytes is mediated through activation of
MAPK-p38, but not MAPK-ERK, or MAPK-JNK [24, 41,
105]. Blocking the MAPK-p38 pathway inhibits the cap-
acity of MAP to induce IL-10 expression, suppress IL-
12, block phagosome acidification, and inhibit organism
killing [41]. MAPK-p38 kinase exists as four isoforms,
alpha, beta, gamma and delta [118]. In case of p38 alpha,
it is the sites Thr180/Tyr182 that become dual phos-
phorylated, signaling activation within the cell. Following
TLR ligation, signaling cascades are activated through
Toll/IL-1 receptor (TIR)-domain-containing adaptor
molecules, such as myeloid differentiation primary re-
sponse protein 88 (MYD88) which consists of a C-
terminal TIR and an N-terminal death domain (DD).
The later interacts with the DD of a serin/threonin pro-
tein kinase, IL-1 receptor-associated kinases (IRAK).
Binding to MyD88 enables IRAK4 to phosphorylate the
subsequently recruited IRAK1, thereby inducing the ac-
tivation of its kinase activity. Autophosphorylated IRAK1
subsequently dissociates from the receptor complex and
associates with TIR-domain containing adaptor protein
inducing IFN-β 6 (TRAF6) [119]. The IRAK1-TRAF6
complex interacts at the plasma membrane with another
preformed complex consisting of TGF-β-activated pro-
tein kinase 1 (TAK1) TAK binding protein1 (TAB1) and
TAB2 or TAB3. This interaction induces phosphoryl-
ation of TAB2/TAB3 and TAK1, leading to their trans-
location to the cytoplasm together with TRAF6 and
TAK1, whereas IRAK1 is degraded at the plasma mem-
brane. In the cytoplasm, TAK1 is then activated, result-
ing in the activation of the MAPK-p38, ERK and JNK.
TAK1 activation also, resulting in the activation of IKKs
(IkB kinases), which then phosphorylate the IκBs (inhibi-
tor of NF-κB). This phosphorylation allows ubiquityla-
tion and subsequent degradation of IκB, thereby
releasing NF-κB. NF-κB is consequently free to translo-
cate into the nucleus and induce the expression of its
target genes [120]. These down-signaling cascade leading
to activation and nuclear translocation of transcription
factors such as specific protein 1(Sp1) [121], activator
protein (AP), CCAAT/enhancer binding protein(C/EBP)
β and δ [122], c-musculoaponeurotic fibrosarcoma factor
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(c-Maf ) [123], nuclear factor κ-B (NFκB) [124], and
phosphorylated cyclic AMP element binding protein
(CREB) [125] playing critical role in the expression of
IL-10. Although, MAPK-p38 pathway is an antimicrobial
suppressive response within macrophages, as a result the
activation of this pathway could enable intracellular sur-
vival of MAP and also induce the production of the
anti-inflammatory cytokine such as IL-10 [41, 69].
NF-κB pathway
Several studies suggested that NF-κB plays a role in
regulating IL-10 production. There are five rel proteins
in NF-kB: RelA (p65), RelB and cRel (which contain
transactivation domains) and p50 and p52 {which are
expressed as the precursor proteins p105 (NF-κB1) and
p100 (NF-κB2)} [126]. Gene knockout studies have also
shown that NF-kB proteins may have both pro and anti-
inflammatory roles. Homodimers of the p50 subunit of
NF-kB, which lack transactivation domains, have been
shown to repress expression of NF-kB target genes and
inhibit inflammation [127]. Further studies have shown
that administration of IL-10 fusion protein inhibited IL-
12p40 production dependent on p50/p105 expression in
macrophages [128]. These studies suggest that NF-kB
may have anti-inflammatory roles by directly inhibiting
the expression of pro-inflammatory genes and by manipu-
lating the expression or activity of anti-inflammatory cyto-
kines such as IL-10 [127]. The transcription of IL-10 is
also promoted by one of NF-kB family member that is
NF-kB1 (p50), where p50 can homodimerize and form a
complex with the transcriptional co-activator CREB-
binding protein to activate transcription, while other Rel
family members appear to play a negligible role in IL-10
transcription [129]. NF-κB1-deficient macrophages have
lower levels of IL-10 expression than control cells follow-
ing TLR activation [112].
STAT pathway
Signal transducer and activators of transcription (STATs)
are a family of transcription factors that play crucial roles
in regulating a number of diverse biological functions in-
cluding cell proliferation, differentiation, apoptosis, in-
flammatory response, immunity, and angiogenesis [130].
There are seven STAT proteins (STATs 1, 2, 3, 4, 5a, 5b,
and 6), which are activated by the signals from cytokine
and growth factor receptors in the plasma membrane and
regulate gene transcription [131]. A unique feature of
STAT proteins includes signal transduction through the
cytoplasm and functioning as transcription factors in the
nucleus [132]. STAT proteins are activated by phosphoryl-
ation of specific tyrosine residues, following which they
form stable homodimers or heterodimers with other
STAT proteins through reciprocal phosphotyrosine-SRC
homology 2 (SH2) domain interactions [133]. STAT
dimers then translocate to nucleus where they regulate
the transcription of a set of specific genes. STAT3 is
unique of all STAT family protein, play important role as a
signaling mediator of IL-6 and IL-10 family members and
other cytokines such as leptin and G-CSF [133]. IL-10 also
induces IL-10 in monocyte-derived macrophages in an
autocrine manner via activation of STAT3 factor [45]. IL-
10 bind to IL-10R1/IL-10R2 receptor complex that will
lead the phosphorylation of cytoplasmic protein Janus kin-
ase (JAK) 1(associated with the IL-10 receptor α chain)
and phosphorylation of tyrosine kinase (Tyk) 2 (associated
with the IL-10 receptor β chain) leads to the phosphoryl-
ation and activation of transcription factor, STAT3 [43),
resulting in up-regulation of IL-10 responsive genes, such
as SOCS3, and downregulation of a number of LPS-
inducible genes including pro-inflammatory cytokines in
peripheral blood mononuclear cells [134]. STAT3 is
critical regulator of IL-10 and have been proposed to
transactivate IL10 gene in macrophage and T cell lines of
mouse or human origin [135]. IL-10 mediates its anti-
inflammatory effects on macrophages by signaling
through STAT3 [43, 45]. STAT3 has been reported to dir-
ectly activate transcription of IL-10 and TGF-β genes
[136]. Moreover, STAT3 has been shown to compete for
binding of NF-kB Rel to the IL-12p35 promoter inhibiting
its transcription [137]. Genetic and biochemical evidence
from both human and mouse systems indicate that STAT3
is required to generate IL-10-induced anti-inflammatory
responses [43].
The role of miRNA in regulation of IL-10 and other
signalling pathways in immune cells in
paratuberculosis infection
The best possible therapeutic strategy towards achieving
the goal of targeting MAPK pathway by itself or its
downstream signaling in paratuberculosis can be
through the regulation of IL-10 directly or via STAT3
pathway. The miRNAs are small, non-coding RNAs mol-
ecules that bind complementary sequences in the 3 un-
translated regions (UTRs) of the target genes [138]. In
the immune system miRNAs play an important role in
the development and differentiation of hematopoietic
subset of cells like, DC development [139]. Recent stud-
ies found that miRNAs have critical role in both innate
and adoptive immune response [140], such as macro-
phage polarization, T cell and B cell differentiation [141].
The role of miRNAs has been investigated in the regula-
tion of IL-10 and its related pathways in immune modu-
lating cells [142, 143]. Feng et al., [144] demonstrated
that miR-466 l up-regulate IL-10 expression in TLR-
triggered macrophages both at mRNA and protein
levels. Some miRNAs are IL-10–dependent such as miR-
187, playing a role in IL-10 mediated suppression of
TNF-α, IL-6, and the p40 subunit of IL-12 (IL-12p40)
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produced by primary human monocytes following acti-
vation of TLR4 [145]. On the other hand several studies
investigated that miRNAs also negatively regulate the
expression of IL-10 and can be used to neutralize the
anti-inflammatory effect of IL-10 in different immune
suppressive diseases. In addition to miR-155, miR-147
also counter regulates IL-10 subsequently promoting
pro-inflammatory functions in TLR-triggered macro-
phages [146]. The overexpression of miR-98 inhibited
TLR4-triggered IL-10 production and promoted COX-2
expression, by targeting the 3’untranslated region of IL-
10 transcripts [147]. Similarly, exogenously mimic miR-
27a negatively regulates the expression of IL-10 in
macrophages stimulated by LPS, while promote pro-
inflammatory cytokines [148]. MiR-689, miR-124, and
miR-155 were the most strongly associated miRNAs pre-
dicted to mediate pro-inflammatory pathways and acti-
vation of M1 phenotype of macrophage [149]. In terms
of both phenotype and function, macrophages display
two well established polarized phenotypes are referred to
as the classically activated macrophages (M1) and the al-
ternatively activated macrophages (M2) [150]. M1
phenotype produce large amounts of pro-inflammatory
cytokines, express high levels of major histocompatibility
complex molecules and are potent killers of pathogens
and tumour cells [151], while M2 phenotype, usually ac-
tivated by the IL-4/IL-13 immune complex, IL-10, or
TGF-β, are associated with an immunosuppressive
phenotype, an enhanced release of anti-inflammatory cy-
tokines [142]. As reported by Ouiment and colleagues
that, miR-33 promote M1 phenotype by up-regulating
the expression of M1 markers such as Il6, Nos2, and
Il1b, while reduced the expression of the M2 macro-
phages markers, Mrc1 (mannose receptor CD206) and
Fizz1/Retnla [152]. Sisi et al., [143] reported that miR-
23a and 27a inhibit the polerization of M2 phenotype
while promote M1 phenotype by targeting 3UTR of
JAK1/STAT6 and IRF4/PPAR-γ. The cluster of miR-23a/
27a/24-2 enhance the production of inflammatory medi-
ators (IL-1b, IL-6, IL-12 and TNF-a) while inhibit anti-
inflammatory cytokine such as IL-10 [144]. In addition
to that other studies reported that miRNAs, such as
miR-155, miR-146a and miR-9 negatively regulated the
activation of MAPK-p38 and JNK signaling pathways
[153]. The activation of JAK-STAT3 pathway playing im-
portant role in the regulation of IL-10 and also inhibit
anti-bactericidal activities of phagocytic cells. Recently it
has been determined that miRNAs also have role in the
regulation of STAT3 expression, such as 23a/27a/24-2
got therapeutic significance by inhibiting JAK1-Stat3
and synergistically promote apoptosis [154]. Recently
it is demonstrated that overexpression of miR-124,
miR-519a and miR-351 inhibit STAT3 by targeting 3
untranslated region of STAT3 [154, 155]. The miR-
204 also inhibits the activation of STAT3 and BCL2
by targeting JAK2 [156].
Apart from miRNAs there are some other compounds
that have role in the regulation of IL-10 or IL-10
dependent pathways in several diseases, such as ammo-
nium trichloro (dioxoethylene-O, O’) tellurate (AS101)
inhibit IL-10 production by dephosphorylation of Stat3,
followed by reduced expression of Bcl-2 [157]. In
addition AS101 deactivate Akt that leads to a decrease
in pGSK3 expression and reduce IL-10 production [158].
Sinuani and colleagues reported that AS101 also nega-
tively regulate TGF-β in uninephrectomized rats [159].
AS101 also got immunemodulatory properties by inhi-
biting anti-inflammatory cytokines, IL-10 while promote
pro-inflammatory cytokines [160]. On the other hand,
Myers et al., found that SD-169, a novel oral inhibitor of
MAPK-p38 [161]. Another important compound that in-
hibits the activation of MAPK/ERK1/2 and IκB kinases is
niclosamide, an FDA-approved anti-helminthic compound,
also down-regulate Stat3 and Bcl-2 family members such as
Mcl-1 [162]. You et al., [163] also investigated the role of
niclosamide in the progression of lung cancer by blocking
STAT3/Bcl2/Bcl-Xl signaling pathway. These compounds
can be used to control the progression of paratuberculosis
by targeting IL-10 regulating pathways in mononuclear
phagocytic cells.
Conclusions
Mycobacterium avium subspecies paratuberculosis (MAP)
is the causative agent of paratuberculosis. MAP not only
lead to high economic losses in livestock sector but also a
potential zoonotic threat by considering a contributing
factor in Crohn’s disease of humans. The hallmark of
MAP reactivation is the failure of the host immune re-
sponse to restrain the bacterial growth. The most critical
immune evasion mechanism of MAP survival in macro-
phages is the activation of MAPK-p38 dependent TLR2-
MyD88 adopter protein. MAPK-p38 activation inhibits
antimicrobicidal activity of macrophages and over expres-
sion of IL-10. It is understood that IL-10 plays a critical
role in maintaining homeostasis in the body by resolving
inflammation during acute infection or any injury, while
high level of IL-10 in paratuberculosis promote the sur-
vival of MAP. The excessive amount of IL-10 reduces the
bactericidal ability of defense cells. IL-10 is used as a
weapon by the bacilli to interfere with proper macrophage
activation during active infections. The pathways involved
in the upregulation of IL-10 such as MAPK can be vital
for developing a therapeutic strategy for the control of
paratuberculosis. Recent studies highlighted the role of
miRNAs in pathogen–host interactions. It has been inves-
tigated that certain miRNAs positively regulates the host
immune response against Mtb. Similarly, different miR-
NAs regulates various signaling components of MAPKp-
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38 pathway as well as anti-inflammatory cytokines. Recent
studies on profiling of miRNAs during clinical and sub-
clinical infection of MAP gave a new perspective to MAP
control via miRNA techniques. These studies shown that
circulating miRNAs in MAP infected animals retain their
integrity under longterm suboptimal storage temperatures
and are considered as potential biomarkers [164, 165] that
can be exploited for devising the future paratuberculosis
control strategies. Apart from miRNAs several com-
pounds such as AS101, SD169 and niclosamide can be
used to target IL-10 mediated anti-inflammatory activity.
The knowledge reviewed about the mechanism of MAP
pathogenesis will likely lead to a better understanding of
paratuberculosis treatment and control.
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